News & Industry Bulletins

Friday, January 8, 2016

The Lure of the Lab: Larry Andrade's unconventional route to R&D leadership

The rise in opiate abuse and the emergence of synthetic drugs with street names like “n-bomb,” “bath salts,” and spice” have increased the demand foraccurate drug testing and monitoring services.

Thursday, July 30, 2015

Dominion Diagnostics Named Among 2015 Winners of Healthiest Employers of Rhode Island

Dominion Diagnostics has been announced by Providence Business News as one of 34 winners in the fourth annual Healthiest Employers of Rhode Island recognition program.  The honor was largely based on Dominion's ACHIEVE Health & Wellness Program.

Monday, June 1, 2015

Arrest Underscores China’s Role in the Making and Spread of a Lethal Drug

Although the use of spice has decreased in recent years, according to some surveys, the drug continues to be sold by street dealers, as well as openly on the Internet and at smoke shops and other retailers, as potpourri or incense with brand names like Scooby Snax and Black Diamond.

Wednesday, May 13, 2015

Dominion Diagnostics Named One of Rhode Island’s 2015 Best Places To Work by Providence Business News

Dominion Diagnostics, a leading national provider of drug testing, medication monitoring, and clinical support services, has been named one of Rhode Island’s Best Places to Work.  

Friday, May 1, 2015

"Flakka" is Latest Synthetic Drug to Worry Experts

A drug known as “flakka” is the latest synthetic compound to raise concern among public health experts, Fox News reports. Flakka is a tweaked version of bath salts.In some cases, Flakka can cause heart palpitations and aggressive, violent behavior, the article notes. Use of the drug can affect the kidneys, leading to kidney failure or death.Flakka use has recently been reported in Florida, Ohio and Texas.

Monday, March 2, 2015

FDA Expands Use of Vyvanse to Treat Binge-Eating Disorder

The drug Vyvanse, which is being aggressively marketed as a treatment for binge eating, is classified by the federal government as having a high potential for abuse, The New York Times reports.

Monday, January 12, 2015

Dominion Diagnostics takes key role in 2015 National Conference on Addiction Disorders

Addiction Professional and Behavioral Healthcare today announced that Dominion Diagnostics is the Title Sponsor of the 2015 National Conference on Addiction Disorders and Behavioral Healthcare Executive Summit, taking place August 1 to 4, 2015, in St. Louis.

Monday, January 5, 2015

Aurora Diagnostics Announces Sale of Greensboro, N.C., Blood Testing Laboratory to Dominion Diagnostics

Aurora Diagnostics, the leading independent specialized laboratory company focused on anatomic pathology, announced today that it has sold its Greensboro, N.C., blood testing clinical laboratory to Dominion Diagnostics, effective December 31, 2014.

Friday, December 5, 2014

Heroin Drug Overdoses Nearly Tripled From 1999 to 2012: CDC

Overdose deaths involving heroin nearly tripled from 1999 to 2012, a new government report concludes. Overall, drug overdose deaths more than doubled. The Centers for Disease Control and Prevention (CDC) found drug overdose deaths rose from 6.1 per 100,000 population in 1999 to 13.1 in 2012. Between 2011 and 2012, the rate of drug-poisoning deaths involving heroin increased 35 percent, from 1.4 per 100,000 to 1.9.

Tuesday, December 2, 2014

Massachusetts General Hospital & Harvard Medical School's Recovery Research Institute (RRI) features findings from recently published research on CARD®, developed by Dominion Diagnostics

The Recovery Research Institute (RRI) at the Massachusetts General Hospital and Harvard Medical School is currently featuring the recently published CARD® research study Systematic Evaluation of “Compliance” to Prescribed Treatment Medications and “Abstinence” from Psychoactive Drug Abuse in Chemical Dependence Programs: Data from the Comprehensive Analysis of Reported Drugs in its monthly newsletter.